AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.07.22	AstraZeneca Presents Exploratory Sub-analyses From HIMALAYA And TOPAZ-1 Trials (RTTNews)
01.07.22	Oxford Biomedica, AstraZeneca Extend COVID-19 Vaccine Manufacturing Partnership (RTTNews)
30.06.22	AstraZeneca: Imfinzi Plus Chemotherapy Improved PCR In Resectable Lung Cancer - Quick Facts (RTTNews)
27.06.22	AstraZeneca : Lynparza Recommended For Approval In EU For High-risk Early Breast Cancer (RTTNews)
27.06.22	AstraZeneca : Enhertu Recommended For Approval In EU By CHMP For Metastatic Breast Cancer (RTTNews)
23.06.22	AstraZeneca: Phase III Data Show Significant Copper Mobilization From Tissues With ALXN1840 (RTTNews)
22.06.22	Biocartis In Deal With AstraZeneca To Develop Companion Diagnostic Test For Tagrisso (RTTNews)
21.06.22	AstraZeneca Posts Positive Interim Data In Eplontersen Phase III Trial In ATTRv-PN - Quick Facts (RTTNews)
08.06.22	AstraZeneca Reports Positive Trial Data Of Evusheld In Outpatient Treatment Of COVID-19; Stock Up (RTTNews)
06.06.22	AZN : Enhertu Reduces Risk Of Disease Progression Or Death By 50% In Metastatic Breast Cancer (RTTNews)
03.06.22	Innate Pharma : Anti-CD39 Monoclonal Antibody IPH5201 Advances To Phase 2 Study In Lung Cancer (RTTNews)
23.05.22	AstraZeneca: EU Approves Covid-19 Vaccine Vaxzevria As Third Dose Booster (RTTNews)
17.05.22	BenevolentAI Says Achieves Third Milestone In AI-enabled Drug Discovery Collaboration With AZN (RTTNews)
16.05.22	AZN : Phase III Trial Shows PT027 Reduces Risk Of Severe Exacerbation By 27% In Asthma Patients (RTTNews)
13.05.22	Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung Cancer (PR Newswire)
05.05.22	AZN : Phase III Trial Of Farxiga Effective In Treating Heart Failure Regardless Of Ejection Fraction (RTTNews)
05.05.22	AZN : Phase III Trial Of Ultomiris Meets Main Goal In Neuromyelitis Optica Spectrum Disorder (RTTNews)
05.05.22	FDA Oks AstraZeneca's Enhertu To Treat Unresectable Or Metastatic HER2 Positive Breast Cancer (RTTNews)
04.05.22	AZN : Imfinzi Plus Chemotherapy Granted Priority Review In U.S. For Metastatic Biliary Tract Cancer (RTTNews)
29.04.22	AstraZeneca Stock Down On Weak Q1 Profit; Backs FY22 View (RTTNews)
29.04.22	AstraZeneca Q1 Core Profit Rises, Revenue Up 60%: Reiterates FY22 Guidance At CER (RTTNews)
28.04.22	FDA Oks AstraZeneca's Ultomiris For Treatment Of Adult Patients With Generalised Myasthenia Gravis (RTTNews)
27.04.22	AstraZeneca's Enhertu Granted Breakthrough Therapy Designation In U.S. For Metastatic Breast Cancer (RTTNews)
25.04.22	AstraZeneca: FDA Accepts BLA For Tremelimumab In Combination With Imfinzi For Priority Review (RTTNews)
21.04.22	AZN : Evusheld Protects Against Symptomatic COVID-19 For At Least Six Months In Phase III Trial (RTTNews)
19.04.22	AstraZeneca's ENHERTU Granted Priority Review In U.S. For Non-Small Cell Lung Cancer Treatment (RTTNews)
18.04.22	AmoyDx Enters Master Collaboration Agreement With AstraZeneca (RTTNews)
07.04.22	Harbour BioMed Reaches License Deal With AstraZeneca On Bispecific Antibody HBM7022 (RTTNews)
04.04.22	PGA Champion Jason Day Launches Getting Out of the Rough Video Series With AstraZeneca to Support Lung Cancer Biomarker Testing Awareness (PR Newswire)
29.03.22	AstraZeneca Reports Approval Of Ondexxya In Japan - Quick Facts (RTTNews)
25.03.22	AstraZeneca's Evusheld Recommended In EU For COVID-19 Prevention (RTTNews)
24.03.22	AZN: Phase III Trial Of Imfinzi - CRT In Locally Advanced Cervical Cancer Fails To Meet Primary Goal (RTTNews)
21.03.22	AstraZeneca: COVID Drug EVUSHELD Retains Neutralizing Activity Against Omicron Variants (RTTNews)
17.03.22	AstraZeneca's Unit Alexion To Pay $775 Mln To Chugai On Ultomiris Patent Settlement (RTTNews)
14.03.22	AstraZeneca : FDA Asks Additional Data On Fasenra In Chronic Rhinosinusitis With Nasal Polyps (RTTNews)
22.02.22	AstraZeneca, Honeywell To Develop Respiratory Inhalers With Near-zero GWP Propellants (RTTNews)
22.02.22	HONEYWELL TEAMS WITH ASTRAZENECA TO DEVELOP NEXT-GENERATION RESPIRATORY INHALERS THAT USE NEAR-ZERO GLOBAL WARMING POTENTIAL PROPELLANT (PR Newswire)
21.02.22	AZN : ENHERTU Improves PFS & Overall Survival In Phase 3 Trial On HER2 Low Metastatic Breast Cancer (RTTNews)
16.02.22	EU Approves AstraZeneca's Saphnelo To Treat Moderate To Severe Systemic Lupus Erythematosus (RTTNews)
15.02.22	AstraZeneca: Lynparza Plus Abiraterone In Phase III Trial Show Positive Results In MCRPC Patients (RTTNews)
11.02.22	AstraZeneca To Join NASDAQ-100 Index (RTTNews)
10.02.22	AstraZeneca FY21 Core Profit Rises; Revenue Up 41% - Quick Facts (RTTNews)
24.01.22	AstraZeneca: FDA Grants Orphan Drug Designation To Eplontersen For Transthyretin Amyloidosis (RTTNews)
19.01.22	AstraZeneca: Imfinzi Plus Chemotherapy In Phase III Trial Shows Positive Results In BTC Patients (RTTNews)
19.01.22	AZN : Imfinzi Plus Tremelimumab Show Unprecedented Survival In 1st-line Unresectable Liver Cancer (RTTNews)
17.01.22	FDA Decision On Expanded Indication For AstraZeneca/Daiichi's Breast Cancer Drug In Q2 (RTTNews)
13.01.22	AstraZeneca, Amgen Announce Market Availability Of Tezspire - Quick Facts (RTTNews)
13.01.22	AstraZeneca: New Data In Liver, Biliary Tract, Prostate Cancer Treatment With Imfinzi And Lynparza (RTTNews)
13.01.22	AstraZeneca, Scorpion Team Up To Explore New Treatments Against Hard-to-target Cancer Proteins (RTTNews)
13.01.22	AstraZeneca: Trial Shows Vaxzevria Third Dose Strongly Boosts Immunity Against COVID-19 Variants (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	247.50	0.32 %	K V
Sonova Hldg	291.80	-0.34 %	K V
Swisscom	498.20	-0.66 %	K V
Givaudan	3’881.00	-0.67 %	K V
Kuehne+Nagel Int	200.90	-0.69 %	K V
Lonza Grp	518.60	-1.82 %	K V
Holcim	85.24	-2.00 %	K V
Part Grp Hldg	1’191.00	-2.14 %	K V
UBS Group	26.26	-2.34 %	K V
Sika	213.40	-2.38 %	K V

mehr

18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus
03.12.24		Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück
03.12.24		NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer
12.11.24		AstraZeneca-Aktie im Minus: AstraZeneca meldet starkes 3. Quartal und passt Prognose nach oben an
07.11.24		AstraZeneca-Aktie rutscht ab: Festnahme des China-Chefs von AstraZeneca

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

03.12.24

Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück

03.12.24

NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer